CVS · CVS HEALTH Corp · Metrics
$82.89
-2.92 (-3.40%)
At close · Nov 18
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$109.79B
Shares
1.28B
Volume · Nov 18
5.29M
Avg daily vol (3M)
9.11M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
CVS metrics
117 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$85.81
Market cap
$109.79B
Price action
23 metricsPrice change (1W)
-3.6%
Price change (30D)
-7.4%
Price change (3M)
-9.6%
Price change (6M)
-8.9%
Price change (YTD)
+8.1%
Price change (1Y)
+9.4%
Trailing year
Price change (5Y)
-7.5%
52-week high
$110.60
52-week low
$70.08
Change from 52-week high
-22.4%
Change from 52-week low
+22.4%
Annualized volatility
34.2%
Annualized volatility (3M)
36.5%
Implied volatility (30D)
31.7%
IV rank (1Y)
36.6
IV percentile (1Y)
51.8
Beta
0.0
RSI (14D)
43.6
Price vs SMA 50
-3.9%
Price vs SMA 200
-3.9%
Avg volume (3M)
9.11M
Relative volume
1.5
Average dollar volume
$811.96M
Company
3 metricsSector
Healthcare
Industry
Healthcare Plans
Shares outstanding
1.28B
Valuation
12 metricsP / E (TTM)
10.0
Trailing earnings · reciprocal yield 10.0%
PEG ratio
—
EV / revenue
0.4×
reciprocal yield 270.3%
EV / EBITDA
7.9×
reciprocal yield 12.6%
EV / EBIT
10.3×
reciprocal yield 9.7%
P / sales
0.3×
reciprocal yield 383.1%
P / book
1.4
reciprocal yield 73.3%
FCF yield
14.2%
TTM · current market cap
Buyback yield
0.0%
P / FCF
7.1
reciprocal yield 14.2%
P / operating cash flow
5.9
reciprocal yield 17.0%
Earnings yield
10.1%
Historical valuation
8 metricsP / E historical average (3Y)
36.5×
reciprocal yield 2.7%
P / E historical average (5Y)
31.4×
reciprocal yield 3.2%
EV / revenue historical average (3Y)
0.4×
reciprocal yield 269.1%
EV / revenue historical average (5Y)
0.4×
reciprocal yield 237.5%
EV / EBIT historical average (3Y)
17.7×
reciprocal yield 5.7%
EV / EBIT historical average (5Y)
17.3×
reciprocal yield 5.8%
EV / EBITDA historical average (3Y)
10.9×
reciprocal yield 9.1%
EV / EBITDA historical average (5Y)
11.1×
reciprocal yield 9.0%
Dividends & buybacks
7 metricsDividend yield
3.1%
Trailing 12 months
Payout ratio
31.0%
Shareholder yield
—
Dividend / share (TTM)
$2.66
Dividend growth YoY
+0.0%
Dividend growth streak
0
Last ex-dividend
2026-10-22
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-11-04
Profitability
9 metricsGross margin
44.2%
Operating margin
3.6%
Trailing 12 months
Net margin
2.6%
Gross profit (TTM)
$186.06B
Operating profit (TTM)
$15.06B
Net income (TTM)
$11.04B
Trailing 12 months
Diluted EPS (TTM)
$8.60
FCF margin
3.7%
Effective tax rate
8.8%
Growth
11 metricsRevenue growth YoY
+5.4%
Year over year
Net income growth YoY
-61.7%
Revenue (TTM)
$420.61B
Trailing 12 months
EPS growth YoY
-62.0%
Shares change YoY
+1.7%
Year over year · more shares
Revenue CAGR (3Y)
+7.6%
Revenue CAGR (5Y)
+8.4%
EPS CAGR (3Y)
-24.7%
EPS CAGR (5Y)
-23.9%
FCF CAGR (3Y)
-16.6%
FCF CAGR (5Y)
-10.3%
Quality
14 metricsReturn on equity
13.7%
Return on assets
4.3%
Debt / equity
0.8
Current ratio
0.9
EBITDA (TTM)
$19.58B
Free cash flow (TTM)
$15.57B
Quick ratio
0.7
Interest coverage
4.9
Net debt / EBITDA
2.3
Return on invested capital
10.9%
Trailing 12 months
Net cash
−$45.79B
Latest balance sheet
Cash & equivalents
$11.74B
Total assets
$258.07B
Total debt
$60.68B
Cash flow & spend
7 metricsOperating cash flow (TTM)
$18.71B
Capital expenditures (TTM)
$3.14B
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$745.00M
R&D / revenue
—
Stock compensation / revenue
0.2%
Ownership (13F)
9 metrics13F filers
1,987
13F filer change QoQ
-103
Institutional ownership
86.7%
Conviction holders (share of 13F filers)
0.9%
Crowding (high-turnover and private-fund holders)
15.4%
Private-fund adviser ownership
15.0%
Active holders' share change QoQ
-1.4%
Holder tenure
20.0
Price vs estimated holder cost
+8.4%
Ownership (registered funds)
1 metricsIndex-fund ownership
17.6%
Short interest
3 metricsShort interest
1.4%
Latest settlement · 2.8 days to cover
Days to cover
2.8d
Short-squeeze score
54 / 100
Insider activity
2 metricsNet insider buying (90D)
$2.00M
Insider-sentiment score
80 / 100
Risk flags
1 metricsGoing concern
—
Key facts
CIK
64803
CUSIP
126650100
13F (30d)
1823 filings
1708 filers
Visit website
Investor relations